Cleaved-F2R (S42) Antibody

What is Cleaved-F2R (S42) Antibody and what epitope does it specifically detect?

Cleaved-F2R (S42) Antibody is a rabbit polyclonal antibody that specifically detects endogenous levels of the fragment of activated Thrombin Receptor protein (also known as Proteinase-activated receptor 1 or PAR1) resulting from cleavage adjacent to the serine residue at position 42 (S42) . This antibody recognizes the amino acid region 23-72 of human PAR1, which becomes exposed after proteolytic cleavage . The antiserum was produced against a synthesized peptide derived from human PAR1 at the amino acid range 23-72 . This antibody serves as a valuable research tool for studying receptor activation mechanisms in thrombosis and inflammation.

What is the molecular structure and function of F2R and its cleaved form?

F2R (PAR1/Thrombin Receptor) is a G protein-coupled receptor with an observed molecular weight of approximately 47 kDa . Upon activation by proteases like thrombin, F2R undergoes proteolytic cleavage that generates a new N-terminus that functions as a tethered ligand . This high-affinity receptor binds activated thrombin, leading to calcium release from intracellular stores .

The receptor's signaling pathway is mediated through PTX-insensitive G proteins and activation of phospholipase C . The critical cleavage occurs between residues 41-Arg and Ser-42, exposing a new N-terminal sequence that binds to other regions of the receptor itself, triggering conformational changes and downstream signaling . This unique "self-activation" mechanism distinguishes PARs from many other receptor types.

What is the significance of the S42 cleavage site in F2R activation and signaling?

The S42 cleavage site represents a critical regulatory point in F2R function. Proteolytic cleavage at the 41-Arg-|-Ser-42 junction by proteases such as thrombin or cathepsin CTSG results in receptor activation . This precise cleavage generates a new N-terminus starting at S42 that functions as a tethered ligand, inducing conformational changes that initiate signaling cascades .

The site-specific nature of this cleavage is highlighted by the fact that alternative proteolytic processing at different positions can produce opposite functional outcomes. For example, cleavage at the 55-Phe-|-Trp-56 position results in inhibition rather than activation of the receptor . This differential regulation through selective proteolysis demonstrates the sophisticated control mechanisms governing F2R/PAR1 signaling and explains why antibodies that specifically detect the S42 cleavage are valuable research tools.

What validated research applications exist for Cleaved-F2R (S42) Antibody?

The Cleaved-F2R (S42) Antibody has been validated for the following research applications:

The antibody specifically detects endogenous levels of the activated form of the Thrombin Receptor protein resulting from cleavage adjacent to S42 . While not explicitly validated for other techniques, researchers with appropriate controls might explore applications in immunohistochemistry or immunofluorescence, as similar F2R antibodies have been successfully used in these contexts .

What are the optimized protocols for Western Blot analysis using Cleaved-F2R (S42) Antibody?

For optimal Western Blot results with Cleaved-F2R (S42) Antibody, the following protocol is recommended:

• Sample preparation:

  • Lyse cells or tissues in an appropriate buffer containing protease inhibitors

  • Prepare samples under reducing conditions

  • Load 20-50 μg of protein per lane (based on protocols for similar antibodies)

• Electrophoresis and transfer:

  • Separate proteins on a 5-20% SDS-PAGE gel

  • Transfer to nitrocellulose membrane at 150mA for 50-90 minutes

• Blocking and antibody incubation:

  • Block membrane with 5% non-fat milk in TBS for 1-2 hours at room temperature

  • Incubate with Cleaved-F2R (S42) Antibody at 1:500-1:2000 dilution overnight at 4°C

  • Wash with TBS containing 0.1% Tween-20 (3-5 times, 5 minutes each)

  • Incubate with HRP-conjugated anti-rabbit secondary antibody (typically 1:5000)

• Detection:

  • Develop using an enhanced chemiluminescent detection system

  • The cleaved F2R fragments will appear at a lower molecular weight than the full-length receptor (47 kDa)

Positive controls should include samples from tissues known to express F2R, such as placenta tissue lysates or U-87MG cell lysates .

How should researchers optimize ELISA protocols when using this antibody?

For ELISA applications with Cleaved-F2R (S42) Antibody, researchers should consider the following optimization approaches:

• Protocol guidelines:

  • Begin with the manufacturer's recommended dilution of 1:20000

  • Use purified or recombinant cleaved F2R peptide for standard curve generation

  • Block with 1-3% BSA in PBS (note that the antibody formulation contains 0.5% BSA)

  • Incubate the primary antibody for 2 hours at room temperature or overnight at 4°C

  • Use an appropriate HRP-conjugated anti-rabbit detection antibody

• Optimization strategy:

  • Perform checkerboard titration with different antigen concentrations and antibody dilutions

  • Test multiple blocking agents to minimize background

  • Evaluate different incubation times and temperatures

  • Compare signal-to-noise ratios across conditions

• Considerations specific to this antibody:

  • The antibody formulation contains 50% glycerol, 0.5% BSA, and 0.02% sodium azide , which may affect certain ELISA formats

  • The high recommended dilution (1:20000) suggests high affinity and specificity, allowing for sensitive detection

  • Maintain consistency in sample preparation to ensure reproducible detection of cleaved receptor forms

How can researchers distinguish between different cleaved forms of F2R/PAR1?

Distinguishing between different cleaved forms of F2R/PAR1 requires careful experimental design:

• Antibody selection strategy:

  • Use site-specific antibodies targeting distinct cleavage sites

  • The Cleaved-F2R (S42) Antibody specifically detects cleavage at the S42 position

  • For detecting alternative cleavage sites (e.g., 55-Phe-|-Trp-56), different cleavage-specific antibodies would be required

• Complementary analytical approaches:

  • Employ SDS-PAGE with high-resolution gradient gels to separate fragments of similar sizes

  • Combine with mass spectrometry to definitively identify cleavage positions

  • Use N-terminal sequencing of immunoprecipitated receptor fragments

• Functional correlation:

  • Correlate antibody detection with functional assays, as different cleavage forms have distinct signaling outcomes

  • The 41-Arg-|-Ser-42 cleavage results in activation, while 55-Phe-|-Trp-56 cleavage causes inhibition

• Protease-specific induction:

  • Generate specific cleavage forms using purified proteases (thrombin vs. cathepsin G)

  • Compare these standards with experimental samples to identify the predominant cleavage forms

This multi-faceted approach allows researchers to determine which specific cleaved forms are present under different physiological or pathological conditions.

How does phosphorylation of the C-terminal tail affect antibody recognition of cleaved F2R?

The relationship between C-terminal phosphorylation and N-terminal cleavage detection requires careful consideration:

• Post-translational modification sequence:

  • F2R undergoes phosphorylation in its C-terminal tail following activation

  • This phosphorylation likely mediates desensitization prior to receptor uncoupling and internalization

  • The temporal relationship between cleavage and phosphorylation provides information about receptor activation stage

• Epitope considerations:

  • The Cleaved-F2R (S42) Antibody recognizes the 23-72 amino acid region

  • C-terminal phosphorylation occurs distant from this epitope

  • Direct interference with antibody binding is unlikely, but conformational changes may indirectly affect epitope accessibility

• Experimental approach for dual modification detection:

  • Use the Cleaved-F2R (S42) Antibody in conjunction with phospho-specific antibodies

  • Perform sequential immunoprecipitations to isolate receptor populations with both modifications

  • Consider 2D gel electrophoresis to separate receptor forms based on both size and charge (phosphorylation adds negative charge)

• Functional implications:

  • Receptors positive for both cleavage and phosphorylation likely represent activated receptors undergoing desensitization

  • The ratio between cleaved-only and cleaved-phosphorylated forms may indicate the balance between receptor activation and deactivation mechanisms

What cross-reactivity considerations should researchers address when using this antibody?

When using Cleaved-F2R (S42) Antibody, researchers should address several potential cross-reactivity issues:

• Homologous protein recognition:

  • The antibody reacts with human, rat, and mouse F2R , reflecting conservation of the epitope

  • Other PAR family members (PAR2, PAR3, PAR4) share structural similarities that could potentially lead to cross-reactivity

  • Validation in PAR1/F2R knockout models can confirm specificity

• Alternative cleavage product discrimination:

  • F2R can be cleaved at multiple sites by different proteases

  • The antibody specifically detects cleavage adjacent to S42

  • Potential cross-reactivity with other cleavage forms should be evaluated using defined standards

• Application-specific considerations:

  • For Western blot: Run appropriate controls and confirm the molecular weight corresponds to the expected cleaved fragment

  • For ELISA: Perform competitive binding assays with the immunizing peptide

  • For immunohistochemistry (if attempted): Include absorption controls with the specific peptide antigen

• Background reduction strategies:

  • The antibody was affinity-purified using an epitope-specific immunogen , which enhances specificity

  • Use appropriate blocking reagents compatible with the antibody formulation (contains 0.5% BSA)

  • Include isotype controls at equivalent concentrations

What are the optimal sample preparation methods for detecting cleaved F2R (S42)?

Optimal sample preparation is critical for preserving and detecting the cleaved form of F2R:

• Cell/tissue processing:

  • Process samples rapidly to minimize artifactual proteolysis

  • For adherent cells, consider direct lysis in the culture dish

  • For tissues, flash-freeze immediately after collection and pulverize under liquid nitrogen

• Lysis buffer composition:

  • Use buffers containing 1% NP-40 or Triton X-100 for membrane protein extraction

  • Include protease inhibitor cocktail carefully selected to preserve natural cleavage events while preventing artifactual degradation

  • Consider adding phosphatase inhibitors if studying both cleavage and phosphorylation

• Processing conditions:

  • Maintain samples at 4°C throughout processing

  • Centrifuge lysates at high speed (≥10,000 × g) to remove cellular debris

  • Avoid repeated freeze-thaw cycles

• Storage recommendations:

  • Aliquot samples to avoid freeze-thaw cycles

  • Store at -80°C for long-term storage

  • Follow the antibody storage recommendation (-20°C for up to 1 year)

• Application-specific considerations:

  • For Western blot: Prepare samples in reducing conditions with standard Laemmli buffer

  • For ELISA: Dilute samples in buffers compatible with the antibody formulation (PBS containing glycerol and BSA)

How should researchers troubleshoot common issues with Cleaved-F2R (S42) Antibody detection?

When encountering problems with Cleaved-F2R (S42) Antibody, consider the following troubleshooting strategies:

• No signal or weak signal:

  Problem	Solution
  Insufficient antigen	Confirm F2R expression and cleavage; treat samples with thrombin to induce cleavage
  Antibody dilution too high	Try lower dilution within the recommended 1:500-1:2000 range for WB
  Poor transfer efficiency	Optimize transfer conditions for membrane proteins
  Insufficient exposure	Increase exposure time for Western blots
  Antibody degradation	Store according to recommendations (-20°C, avoid freeze-thaw cycles)

• High background:

  Problem	Solution
  Insufficient blocking	Increase blocking time or concentration
  Antibody concentration too high	Try higher dilution within recommended range
  Inadequate washing	Add more wash steps with TBS-T
  Secondary antibody issues	Decrease secondary antibody concentration
  Buffer incompatibility	Consider that antibody contains 0.5% BSA ; adjust blocking accordingly

• Multiple or unexpected bands:

  Problem	Solution
  Multiple cleavage forms	Compare with positive controls treated with specific proteases
  Degradation during processing	Review protease inhibitor cocktail composition
  Post-translational modifications	Consider phosphorylation status which can alter migration
  Non-specific binding	Increase antibody dilution; use peptide competition assays

• Poor reproducibility:

  Problem	Solution
  Variable cleavage state	Standardize activation conditions
  Sample preparation inconsistency	Document and standardize lysis and processing protocols
  Antibody lot variation	Record lot numbers and prepare internal standards
  Storage degradation	Use fresh aliquots for critical experiments

What positive controls should be used for validating Cleaved-F2R (S42) Antibody performance?

Proper validation of Cleaved-F2R (S42) Antibody requires appropriate positive controls:

• Cell and tissue-based controls:

  • Human placenta tissue lysates have been validated for F2R detection

  • U-87MG cell lysates show good expression of F2R

  • Human breast cancer and rectal cancer tissues are suitable for IHC applications if attempted

  • Platelet-rich samples naturally express high levels of PAR1/F2R

• Treatment-induced controls:

  • Samples treated with thrombin to induce specific cleavage at the S42 site

  • Cathepsin G-treated samples (cleaves at the same 41-Arg-|-Ser-42 site)

  • Time-course samples to capture the dynamic nature of receptor activation

• Recombinant standards:

  • Synthesized peptide corresponding to amino acids 23-72 of human PAR1

  • This matches the immunogen used to generate the antibody

  • Can be used for calibration curves in quantitative applications

• Negative controls:

  • F2R/PAR1 knockout or knockdown samples

  • Pre-absorption of the antibody with the immunizing peptide

  • Samples treated with protease inhibitors to prevent cleavage

• Cross-species validation:

  • The antibody reacts with human, rat, and mouse samples

  • Comparative analysis across species can confirm specificity and conservation of the epitope